These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6149570)

  • 21. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
    Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
    Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Depot neuroleptics in social psychiatric practice].
    Pruss U; Rose HK; Zechner A
    Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Practical aspects of drug resistance in schizophrenia].
    Jarema M; Kucińska M
    Psychiatr Pol; 2000; 34(5):721-40. PubMed ID: 11202015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of personality factors on the success of psychopharmacotherapy].
    Rüger U
    Psychiatr Prax; 1985 Jan; 12(1):5-7. PubMed ID: 2858900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards the improvement of compliance: the significance of psycho-education and new antipsychotic drugs.
    Gaebel W
    Int Clin Psychopharmacol; 1997 Feb; 12 Suppl 1():S37-42. PubMed ID: 9179642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An audit in general adult psychiatry service.
    Udumaga E; Mannion L
    Ir Med J; 2010 Apr; 103(4):123-4. PubMed ID: 20486321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications for long-term pharmacological treatment of schizophrenic syndromes.
    Perris C
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):149-58. PubMed ID: 10585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients.
    Pietzcker A; Poppenberg A; Schley J; Müller-Oerlinghausen B
    Arch Psychiatr Nervenkr (1970); 1981; 229(4):315-29. PubMed ID: 6111989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of perazine-induced enteritis--allergy or pseudoallergy?
    Meya U; Möller B; Renfordt E; Lobeck H
    Pharmacopsychiatry; 1985 Jul; 18(4):263-6. PubMed ID: 2862649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early serum levels of neuroleptics do not predict therapeutic response in schizophrenia.
    Gaebel W; Müller-Oerlinghausen B; Schley J
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):891-900. PubMed ID: 1355303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Perazine therapy. Seminar, Hamburg, 12-14 November 1992].
    Nervenarzt; 1993 Jan; 64(1 Suppl):1-8. PubMed ID: 7477594
    [No Abstract]   [Full Text] [Related]  

  • 35. Lithium in schizophrenia.
    Wilson WH
    Hosp Community Psychiatry; 1986 Dec; 37(12):1267. PubMed ID: 2879785
    [No Abstract]   [Full Text] [Related]  

  • 36. One man's schizophrenic illness.
    Gallant D
    Br Med J; 1979 Jun; 1(6177):1565. PubMed ID: 37979
    [No Abstract]   [Full Text] [Related]  

  • 37. Perazine for schizophrenia.
    Leucht S; Helfer B; Hartung B
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD002832. PubMed ID: 24425538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What do patients in a lithium outpatient clinic know about lithium therapy?
    Schaub RT; Berghoefer A; Müller-Oerlinghausen B
    J Psychiatry Neurosci; 2001 Sep; 26(4):319-24. PubMed ID: 11590971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The outpatient clinic for patients under chronic lithium or neuroleptic treatment as a phase-IV research tool.
    Pietzcker A; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1984 Sep; 17(5):162-7. PubMed ID: 6149570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Methodological considerations, sample population, and research variables.
    Rein W; Schied HW; Breyer-Pfaff U; Straube E
    Pharmacopsychiatria; 1983 Sep; 16(5):147-51. PubMed ID: 6140693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.